A new platform developed by researchers at the University of Texas MD Anderson Cancer Center quickly finds and isolates rare, tumor-reactive immune cells that are especially good at recognizing and attacking cancer cells, even without knowing which tumor targets are recognized by the immune cells. This approach addresses a major bottleneck in immunotherapy development and could accelerate the creation of personalized treatments.
🛡️
Just a quick checkWe’re checking your connection to prevent automated abuse
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Scientists supercharge immune cells to destroy cancer more effectively | 0 | 9.11 | 17-04-2026 |
| 2 | A hidden immune backup system could supercharge mRNA cancer vaccines | 0 | 9.29 | 09-07-2026 |
| 3 | Rare stem T cells may hold the key to fighting chronic diseases | 5 | 7 | 01-07-2026 |
| 4 | Tumor on a chip reveals how pancreatic cancer hijacks immune cells in real time | 5 | 8 | 07-07-2026 |
| 5 | A Trojan horse cancer therapy shows stunning results | 0 | 7.27 | 30-01-2026 |
| 6 | Ученые нашли способ создать источник клеток для борьбы с раком | 5 | 7 | 06-07-2026 |
| 7 | New mechanism may help predict and improve macrophage-targeted cancer immunotherapy | 0 | 7.03 | 14-08-2026 |
| 8 | New blood test for noncoding RNA significantly improves cancer detection | 7 | 8 | 31-08-2023 |
| 9 | This new antibody may stop one of the deadliest breast cancers | 0 | 8.13 | 23-01-2026 |
| 10 | Researchers uncover 'hidden key' to immunotherapy for intractable brain tumors | 2 | 8 | 20-07-2026 |